FDA officials have recently approved a drug known as Acterma for treating moderate to severe forms of rheumatoid arthritis in patients non-r...

Federal regulators have approved a new class of rheumatoid arthritis drug created by South San Francisco's Genentech. The drug, called A...

Recent insights into the processes driving the autoimmune attack underlying rheumatoid arthritis are leading to promising new classes of tre...

An experimental oral drug from Pfizer could shake up the rheumatoid arthritis market, after impressive results were presented at a medical m...

An experimental oral rheumatoid arthritis drug being developed by Pfizer Inc was significantly more effective than a placebo in a mid-stage ...

A Patient developing rheumatoid arthritis (RA) today should be able to live a relatively normal existence because of new drug treatments, a ...

Belgian drugmaker UCB said Wednesday it received federal approval for an injectable drug to treat arthritis, entering a competitive market d...

A new arthritis drug from Johnson & Johnson has been given a green signal by the Food and Drug Administration (FDA). The drug named Simp...

Under a basic research program specific and Brain Korea 21 program, a joint research team from the Catholic University and St. Vincent Hospi...